ZA853351B - 2-amino-3-ethoxycarbonylamino-6-(p-fluoro-benzylamino)-pyridine gluconate,process for its production and pharmaceutical preparations containing it - Google Patents
2-amino-3-ethoxycarbonylamino-6-(p-fluoro-benzylamino)-pyridine gluconate,process for its production and pharmaceutical preparations containing itInfo
- Publication number
- ZA853351B ZA853351B ZA853351A ZA853351A ZA853351B ZA 853351 B ZA853351 B ZA 853351B ZA 853351 A ZA853351 A ZA 853351A ZA 853351 A ZA853351 A ZA 853351A ZA 853351 B ZA853351 B ZA 853351B
- Authority
- ZA
- South Africa
- Prior art keywords
- ethoxycarbonylamino
- benzylamino
- fluoro
- amino
- production
- Prior art date
Links
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 title abstract 2
- JUUFBMODXQKSTD-UHFFFAOYSA-N N-[2-amino-6-[(4-fluorophenyl)methylamino]-3-pyridinyl]carbamic acid ethyl ester Chemical compound N1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(F)C=C1 JUUFBMODXQKSTD-UHFFFAOYSA-N 0.000 title abstract 2
- 229940050410 gluconate Drugs 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 239000000463 material Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/10—Polyhydroxy carboxylic acids
- C07C59/105—Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843416609 DE3416609A1 (de) | 1984-05-05 | 1984-05-05 | 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA853351B true ZA853351B (en) | 1985-12-24 |
Family
ID=6235001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA853351A ZA853351B (en) | 1984-05-05 | 1985-05-03 | 2-amino-3-ethoxycarbonylamino-6-(p-fluoro-benzylamino)-pyridine gluconate,process for its production and pharmaceutical preparations containing it |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4673666A (fr) |
| EP (1) | EP0160865B1 (fr) |
| JP (1) | JPS60239469A (fr) |
| KR (1) | KR850008678A (fr) |
| AT (1) | ATE33638T1 (fr) |
| AU (1) | AU4194385A (fr) |
| BG (1) | BG44537A3 (fr) |
| CA (1) | CA1263398A (fr) |
| CS (1) | CS248743B2 (fr) |
| DD (1) | DD236927A5 (fr) |
| DE (2) | DE3416609A1 (fr) |
| DK (1) | DK157016C (fr) |
| ES (1) | ES542817A0 (fr) |
| FI (1) | FI80443C (fr) |
| GR (1) | GR851065B (fr) |
| HU (1) | HU193753B (fr) |
| IE (1) | IE57766B1 (fr) |
| IL (1) | IL75086A (fr) |
| MC (1) | MC1651A1 (fr) |
| NO (1) | NO851772L (fr) |
| PL (1) | PL253202A1 (fr) |
| PT (1) | PT80386B (fr) |
| SU (1) | SU1398772A3 (fr) |
| YU (1) | YU71785A (fr) |
| ZA (1) | ZA853351B (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2733151B1 (fr) * | 1995-04-20 | 1997-05-23 | Seppic Sa | Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines |
| US6689370B1 (en) | 1995-04-20 | 2004-02-10 | Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) | Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
| US6117432A (en) * | 1995-04-20 | 2000-09-12 | Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) | Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
| US6821995B1 (en) | 1999-12-01 | 2004-11-23 | Duke University | Method of treating batten disease |
| DE10327674A1 (de) * | 2003-06-20 | 2005-01-05 | Awd.Pharma Gmbh & Co. Kg | Injizierbare Darreichungsform von Flupirtin |
| US20080279930A1 (en) * | 2007-05-07 | 2008-11-13 | Bernd Terhaag | Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof |
| EP2350009B1 (fr) * | 2008-06-09 | 2016-03-16 | TEVA GmbH | Sels sulfonate de flupirtine |
| EA020545B1 (ru) | 2008-06-09 | 2014-12-30 | Авд. Фарма Гмбх Унд Ко. Кг | Соли карбоновой кислоты 2-амино-3-карбэтоксиамино-6-(4-фторбензиламино)пиридина |
| DE102010030053A1 (de) | 2010-06-14 | 2011-12-15 | Awd.Pharma Gmbh & Co.Kg | Injizierbare Darreichungsform von Flupirtin |
| WO2012004391A1 (fr) | 2010-07-09 | 2012-01-12 | K.H.S. Pharma Holding Gmbh | Procédé de préparation de maléate de flupirtine |
| CN102850265B (zh) * | 2011-06-29 | 2015-11-25 | 陈小花 | 一种氟吡汀偶联物及其制备方法和用途 |
| CN102351786A (zh) * | 2011-11-01 | 2012-02-15 | 东南大学 | 一种氟吡汀丙二酸盐及其制备方法 |
| CN103910674B (zh) * | 2013-12-19 | 2015-12-02 | 天津红日药业股份有限公司 | 用于马来酸氟吡汀分析中的参比化合物 |
| CN104974087A (zh) * | 2015-01-30 | 2015-10-14 | 吉林修正药业新药开发有限公司 | 一种氟吡汀二聚体的合成方法 |
| DE102017007385A1 (de) | 2017-08-02 | 2019-02-07 | Christoph Hoock | Maleatfreie feste Arzneimittelformen |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3133519A1 (de) * | 1980-09-13 | 1982-06-09 | Degussa Ag, 6000 Frankfurt | "2-amino-3-carbethoxyamino-6-(p-fluor-benzylamino)-pyridin-maleat" |
| US4481205A (en) * | 1980-09-13 | 1984-11-06 | Degussa Aktiengesellschaft | 2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate |
-
1984
- 1984-05-05 DE DE19843416609 patent/DE3416609A1/de not_active Withdrawn
-
1985
- 1985-04-19 EP EP85104746A patent/EP0160865B1/fr not_active Expired
- 1985-04-19 DE DE8585104746T patent/DE3562242D1/de not_active Expired
- 1985-04-19 AT AT85104746T patent/ATE33638T1/de not_active IP Right Cessation
- 1985-04-26 SU SU853884101A patent/SU1398772A3/ru active
- 1985-04-29 YU YU00717/85A patent/YU71785A/xx unknown
- 1985-04-30 CS CS853157A patent/CS248743B2/cs unknown
- 1985-05-01 US US06/729,413 patent/US4673666A/en not_active Expired - Lifetime
- 1985-05-02 DD DD85275890A patent/DD236927A5/de unknown
- 1985-05-02 GR GR851065A patent/GR851065B/el unknown
- 1985-05-02 DK DK198785A patent/DK157016C/da not_active IP Right Cessation
- 1985-05-03 IL IL75086A patent/IL75086A/xx unknown
- 1985-05-03 NO NO851772A patent/NO851772L/no unknown
- 1985-05-03 PT PT80386A patent/PT80386B/pt unknown
- 1985-05-03 BG BG070073A patent/BG44537A3/xx unknown
- 1985-05-03 HU HU851691A patent/HU193753B/hu unknown
- 1985-05-03 MC MC851765A patent/MC1651A1/fr unknown
- 1985-05-03 FI FI851752A patent/FI80443C/fi not_active IP Right Cessation
- 1985-05-03 AU AU41943/85A patent/AU4194385A/en not_active Abandoned
- 1985-05-03 ES ES542817A patent/ES542817A0/es active Granted
- 1985-05-03 ZA ZA853351A patent/ZA853351B/xx unknown
- 1985-05-03 PL PL25320285A patent/PL253202A1/xx unknown
- 1985-05-03 CA CA000480723A patent/CA1263398A/fr not_active Expired
- 1985-05-03 IE IE1117/85A patent/IE57766B1/en not_active IP Right Cessation
- 1985-05-04 KR KR1019850003047A patent/KR850008678A/ko not_active Application Discontinuation
- 1985-05-07 JP JP60095714A patent/JPS60239469A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3163867D1 (en) | Novel substituted pyrazinyl-1,2,4-oxadiazol-5-ones, a process for preparing same and a pharmaceutical composition containing same | |
| IL67697A (en) | 6-substituted-s-triazolo(3,4-a)phthalazine derivatives,their preparation and pharmaceutical compositions containing them | |
| ZA853351B (en) | 2-amino-3-ethoxycarbonylamino-6-(p-fluoro-benzylamino)-pyridine gluconate,process for its production and pharmaceutical preparations containing it | |
| HU913216D0 (en) | Process for the production of saturated hydroxy-alkyl-kinoline acids, and of medical preparations containing them | |
| EP0044453A3 (en) | New benzisoselenazolones, process for producing the same and pharmaceutical preparations containing the same | |
| ES8801198A1 (es) | Un procedimiento para la preparacion de delta 22 o delta 23 -26,-26,26,27,27,27-hexafluoro-1alfa,25-dihidroxicolecalci- ferol | |
| EP0228701A3 (en) | 2-iodo-perfluoro-2-methylathanes, process for their production and their application | |
| HU913430D0 (en) | 2-substituted-methyl-aryl-carboxylates, medical preparations containing them and process for their production | |
| HUT35479A (en) | Pesticides containing benzoyl-urea-derivatives and process for the production of the benzoyl-urea-derivatives, as well as of pharmaceutucal preparations containing them | |
| GB2106109B (en) | Novel polycyclic polyazaheterocycles, processes for their manufacture and pharmaceutical preparations containing them | |
| GB8727814D0 (en) | Process for sterilising packing material | |
| HUT36783A (en) | Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane | |
| EP0069154A4 (fr) | Nouveaux composes de thiazole, procede de preparation, et composition medicinale en contenant. | |
| CS346691A3 (en) | Complexes containing s-(+)-phenylalkanoic acids and alpha-hydroxyalkanoic acids | |
| IL65541A0 (en) | Alkylamino-2-propanols,process for their preparation and pharmaceutical preparations containing same | |
| ZA815621B (en) | Novel polyazaheterocyclic compounds,process for their manufacture and pharmaceutical preparations containing them | |
| IL76380A0 (en) | Benzazole derivatives,processes for their production and pharmaceutical preparations containing such compounds and the use thereof | |
| EP0216585A3 (en) | 2,6,7-trisubstituted-3-methylenebicyclo û3.3.0¨octanes and process for production thereof | |
| HU904211D0 (en) | Process for the production of medical preparations containing 10-amino-5,6-dihydro-11h-dibenzo/b,e/azepin-6,11-dion and its derivatives | |
| IL69624A0 (en) | 1,2,3,4-tetrahydro-1-aminomethyl-4-phenyl-isoquinolines and their preparation | |
| IE873394L (en) | Material for treatment of ammonia. | |
| DE3267376D1 (en) | Quinidines, process for their preparation and their pharmaceutical application | |
| ZA846432B (en) | 7alpha-substituted 3-oxo-17alpha-pregn-4-ene-21,17-carbolactones,process for their production,and pharmaceutical preparations containing same | |
| GB2155482B (en) | Process for the production of protein containing material | |
| HU202408B (en) | Process for producing leather-regenerating extracts, and pharmaceutical compositions containing them |